99mTc-ADAPT6 SPECT-based Non-invasive Quantification of HER2-expression in Breast Cancer With Metastatic Lymph Nodes
NCT05412446
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Female
Interventions
DRUG:
ADAPT6-SPECT
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Collaborators
[object Object]